9.2.1 ABSTRACT: COMPARATIVE PATHOLOGY Director: Cathy S. Carlson, DVM, PhD, Diplomats ACVP The Comparative Pathology Shared Resource provides expert veterinary pathology support for Cancer Center members who use laboratory animals in their research. Three full-time histotechnicians provide services that include generation of histolpgical sections from frozen and formalin fixed tissues, detection of antigens by immunohistochemistry, and development of new immunohistochemical protocols. Four boardcertified veterinary pathologists provide assistance with project design, evaluation of gross lesions, interpretation of changes in histological sections (both routine sections and immunohistbchemistry preparations), immunohistochemistry technique development, and imaging services. In the next grant cycle, histomorphometry services that will allow quantitation of gross and microscopic tissue changes as well as quantitation of immunohistochemistry results will be included. Having a dedicated group of veterinary pathologists with research expertise available to assist Cancer Center investigators with projects involving animal tissues provides a critical resource for some projects and is essential for publications involving pathological changes in tissues. The marked growth of this resource over the past 5 years is a testament to its value to the Cancer Center. Its location in the College of Veterinary Medicine at the University of Minnesota is easily accessible to Cancer Center investigators. Submission of samples and communication of results is further facilitated by a courier service, electronic communications, and the weekly on-site availability of one of the pathologists at the Cancer Center for consultation on projects. Cancer Center members are given priority for all services offered by the shared resource. Although projects are usually done on a first-come, first-served basis, an advisory board is in place to provide advice regarding prioritization of projects when this is needed.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Sarver, Aaron L; Murray, Collin D; Temiz, Nuri A et al. (2016) MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer. Cell Cycle 15:881-5
Diep, Caroline H; Knutson, Todd P; Lange, Carol A (2016) Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Mol Cancer Res 14:141-62
Yun, Young Sung; Kim, Kwan Hyun; Tschida, Barbara et al. (2016) mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress. Mol Cell 61:625-39
Yan, Y; Hanse, E A; Stedman, K et al. (2016) Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells. Cell Death Differ 23:1232-42
Beura, Lalit K; Hamilton, Sara E; Bi, Kevin et al. (2016) Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532:512-6
Than, B L N; Linnekamp, J F; Starr, T K et al. (2016) CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35:4179-87
Struntz, Nicholas B; Harki, Daniel A (2016) Catch and Release DNA Decoys: Capture and Photochemical Dissociation of NF-κB Transcription Factors. ACS Chem Biol 11:1631-8
Knorr, David A; Wang, Hongbo; Aurora, Mukta et al. (2016) Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 22:825-33
Glasgow, Michelle; Vogel, Rachel Isaksson; Burgart, Jennifer et al. (2016) Long term follow-up of a phase II trial of multimodal therapy given in a ""sandwich"" method for stage III, IV, and recurrent endometrial cancer. Gynecol Oncol Res Pract 3:6
Felices, Martin; Lenvik, Todd R; Davis, Zachary B et al. (2016) Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells. Methods Mol Biol 1441:333-46

Showing the most recent 10 out of 763 publications